In vitro cleavage of collagen mRNA in Ito cells by ribozyme

核酶对 Ito 细胞中胶原蛋白 mRNA 的体外裂解

基本信息

  • 批准号:
    06670584
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

1. Purification of lto cellsRat lto cells were separated by centrifugation using metrizamide solution after perfusion and digestion of the liver with collagenase.2. Synthesis of target RNARat type l collagen alpha (1)cDNA was inserted into pBluescript and sequenced by dye primer method. It was confirmed that this cDNA had Gly-X-Y sequence, specific for collagen genes. The target RNA was synthesized by in vitro transcriprtion using [^<32>P]-UTP.3. Synthesis of ribozymeThe several regions with GUC sequence in target RNA were selected and hammerhead ribozyme complimentary to such regions was designed. The ribozyme was synthesized by in vitro transcription from template DNA,which was made from PCR products using chemically synthesized oligonucleotides.4. In vitro cleavage of collagenmRNA by ribozymeThe target RNA (collagen mRNA) was incubated with ribozyme at 37゚C and the cleaved fragments of collagen mRNA were detected by electrophoresis and autoradiograph. The cleavage activity was detected since 30 min after incubation and approximately 70% of collagen mRNA was cleaved at maximum. The optimal conditions were a target/ribozyme ratio of 1/1 (molar basis) and a MgCl_2 concentration of 10 mM.5. Effect of ribozyme on expression of collagen mRNA in lto cellsIto cells were incubated with the addition of ribozyme and the expression of collagen mRNA was determined by Northern blotting using radiolabeled oligo DNA prove complimentary to collagen mRNA.The cleavage activity was not sufficiently detected. We are planning the transfer of ribozyme into lto cells using adenovirus vectors.
1. lto细胞的纯化方法:1.大鼠肝脏灌流,胶原酶消化后,用甲泛葡胺溶液离心分离lto细胞.目的RNA的合成将1型胶原α(1)的cDNA插入pBluescript中,用染料引物法测定其序列。证实该cDNA具有Gly-X-Y序列,对胶原基因具有特异性。通过使用[3P]-UTP体外转录合成靶RNA。<32>核酶的合成选择了靶RNA中含有GUC序列的几个区域,设计了与这些区域互补的锤头状核酶。以化学合成的核苷酸为模板,以PCR产物为模板DNA,体外转录合成核酶.核酶对胶原mRNA的体外切割将靶RNA(胶原mRNA)与核酶在37 ℃孵育,通过电泳和放射自显影检测胶原mRNA的切割片段。从孵育后30分钟起检测到切割活性,并且最大切割约70%的胶原mRNA。最佳条件是靶/核酶比为1/1(摩尔基础)和MgCl_2浓度为10 mM。5.核酶对lto细胞胶原mRNA表达的影响将lto细胞与核酶共同孵育,用放射性标记的寡聚DNA进行北方印迹分析,以确定与胶原mRNA互补的寡聚DNA对lto细胞胶原mRNA表达的影响。我们正计划用腺病毒载体将核酶转移到lto细胞中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAGAWA Tatehiro其他文献

KAGAWA Tatehiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAGAWA Tatehiro', 18)}}的其他基金

Impact of butyrate-producing bacteria in the gut on fatty liver diseases.
肠道中产生丁酸盐的细菌对脂肪肝疾病的影响。
  • 批准号:
    18K11002
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Comprehensive study to elucidate molecular mechanisms behind intrahepatic cholestasis
综合研究阐明肝内胆汁淤积背后的分子机制
  • 批准号:
    22590746
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of intrahepatic cholestasis and biochemical analysis of bile salt export pump(ABCB 11)
肝内胆汁淤积机制及胆盐输出泵生化分析(ABCB 11)
  • 批准号:
    17590681
  • 财政年份:
    2005
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
INTRACELLULAR TRAFFICKING MECHANISM OF TRANSPORTERS LOCATED ALONG THE CANALICULAR MEMBRANE OF HEPATOCYTES
肝细胞小管膜转运蛋白的细胞内转运机制
  • 批准号:
    10670508
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-proliferative effect of K-ras antisense oligodeoxynucleotides on pancreatic cancer cell line
K-ras反义寡聚脱氧核苷酸对胰腺癌细胞株的抗增殖作用
  • 批准号:
    08670627
  • 财政年份:
    1996
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis
他汀类药物对肝硬化患者蛋白质组 HCC 风险特征的治疗调节
  • 批准号:
    10853142
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Elucidation of the Mechanism of Regenerative Insufficiency in Advanced Liver Cirrhosis Caused by Intestinal Bacterial Extracellular Vesicles and Development of Prevention and Treatment Methods
肠道细菌细胞外囊泡所致晚期肝硬化再生不足机制的阐明及防治方法的开发
  • 批准号:
    22H02866
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
  • 批准号:
    10487561
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
肝硬化网络:临床研究中心 - 梅奥诊所
  • 批准号:
    10487453
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
肝硬化结果预防的策略和治疗:STOP-C 肝硬化网络
  • 批准号:
    10492742
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
肝硬化网络:纵向和临床试验研究
  • 批准号:
    10696089
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
肝硬化结果预防的策略和治疗:STOP-C 肝硬化网络
  • 批准号:
    10311423
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
  • 批准号:
    10700058
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Liver Cirrhosis Network: Clinical Research Centers
肝硬化网络:临床研究中心
  • 批准号:
    10308126
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
肝硬化网络:纵向和临床试验研究
  • 批准号:
    10480915
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了